On August 20, Axinn partner Chad Landmon spoke at ACI’s Paragraph IV on Virtual Trial COVID-19 Edition Virtual Conference.

Chad spoke on, "Finding Solutions to COVID-Related Pharmaceutical Patent Litigation Delays: Addressing Brand and Generic Concerns in the District Courts and at the PTAB." This panel examined how COVID-19 is causing havoc on ANDA litigation timetables established under Hatch-Waxman. Panelists analyzed whether the use of virtual media has been useful in mitigating litigation disruption.